SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000928464-12-000195
Filing Date
2012-08-08
Accepted
2012-08-08 17:10:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 amlnsch13damd15080812.htm SC 13D/A 141355
  Complete submission text file 0000928464-12-000195.txt   143075
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42168 | Film No.: 121017601
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ICAHN ASSOCIATES CORP. 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153
Business Address C/O ICAHN ASSOCIATES CORP. 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153 212-702-4300
ICAHN CARL C (Filed by) CIK: 0000921669 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 0000